Polypharmacy and potentially inappropriate prescribing in people with type 2 diabetes: An analysis of the Scottish Diabetes Research Network national diabetes cohort
Polypharmazie und potenziell unangemessene Verordnungen bei Menschen mit Typ-2-Diabetes: Analyse der nationalen Diabeteskohorte des Scottish Diabetes Research Network
Diabetic Medicine · 2026-02 · 43 (2)
DOI: 10.1111/dme.70179 ↗Auf einen Blick
In einer schottischen Kohorte mit Typ-2-Diabetes war Polypharmazie häufig. Höheres Alter, weibliches Geschlecht, Deprivation und mehr Komorbiditäten waren mit mehr verordneten Medikamenten verbunden.
Fragestellung
Welche Trends und sozio-demografischen sowie klinischen Faktoren sind mit Polypharmazie und potenziell unangemessener Verordnung bei Menschen mit Typ-2-Diabetes in Schottland assoziiert?
Methode
Retrospektive Kohortenstudie mit landesweiten Daten aus der Scottish Care Information – Diabetes database; Personen ab 40 Jahren mit Typ-2-Diabetes; 2012 bis 2022; Poisson-Mixed-Effects-Modell.
Ergebnisse
387.338 Personen eingeschlossen. Median 9 Medikamente pro Person (IQR 5–13). Adjustierte Medikationszahlen waren höher bei 80+ vs. 40–59 Jahren (RR 1,06; 95 %-KI 1,06–1,06), bei Frauen (1,14; 1,13–1,14), in den ärmsten Quintilen (1,24; 1,23–1,24) und bei 4+ Komorbiditäten (1,12; 1,12–1,13).
Schlussfolgerung der Autor:innen
Das Ausmaß der Polypharmazie unterstreicht laut den Autor:innen die Notwendigkeit regelmäßiger formaler Medikamentenreviews in dieser Population.
Kernaussagen
- 387.338 Personen mit Typ-2-Diabetes wurden analysiert
- Median 9 Medikamente pro Person; bei 65+ median 2 potenziell unangemessene Medikamente
- Mehr Medikamente bei höherem Alter, Frauen, Deprivation und mehr Komorbidität
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Diabetic Medicine, online erschienen am 28.11.2025. Verfasst von William Berthon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Polypharmacy, Diabetes Mellitus, Type 2, Inappropriate Prescribing, Hypoglycemic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetes UK.
Themen: Diabetes mellitus, Medikationssicherheit
Abstract (Originalsprache)
Aims
This study assesses national trends and, socio‐demographic and clinical factors associated with polypharmacy and potentially in appropriate prescribing among people with type 2 diabetes in Scotland from 2012 to 2022.
Methods
Retrospective cohort study using nationwide data from the Scottish Care Information – Diabetes database. Individuals aged ≥40 years with type 2 diabetes were included. Medication counts were based on unique medications dispensed per calendar year. Potentially inappropriate medications were based on the 2023 Beers criteria and applied to people aged over 65 years. A Poisson mixed‐effects model with individual‐level random intercepts assessed the relationship between the number of drug classes dispensed and year, gender, age group and socio‐economic status, Elixhauser comorbidity index and the hospital frailty risk score.
Results
387,338 people were included. The median number of medications dispensed per person was 9 (interquartile range 5–13). Adjusted medication counts were modestly higher in older people (rate ratio [RR] 1.06, 95% confidence interval [CI] 1.06–1.06 at age 80+ compared to 40–59), higher in women (1.14, 1.13–1.14), in more deprived areas (1.24, 1.23–1.24 in the most deprived vs. the most affluent quintile) and in those with higher comorbidity (1.12, 1.12–1.13 in 4+ vs. 0 comorbidities) but not with high frailty risk (1.00, 1.00–1.00). People over 65 were dispensed a median of 2 (IQR 1–3) potentially inappropriate medications. Potentially inappropriate medication showed a stronger association with comorbidity (1.24, 1.23–1.25) and a positive association with high frailty risk (1.24, 1.23–1.25).
Conclusions
The degree of polypharmacy highlights the need for regular formal medication reviews in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Genetics and Cancer, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.
- School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
- Centre for Experimental Therapeutics, University of Liverpool, Liverpool, UK.
- Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK.
ORCID-Profile: Rory J McCrimmon, Peter Hanlon
Förderung
- Diabetes UK
Zitieren
APA
Berthon, W., McGurnaghan, S. J., Blackbourn, L. A. K., Fernandes, A. A. S., Walker, L. E., McCrimmon, R. J., Colhoun, H. M., McAllister, D. A., & Hanlon, P. (2026). Polypharmacy and potentially inappropriate prescribing in people with type 2 diabetes: An analysis of the Scottish Diabetes Research Network national diabetes cohort. Diabetic Medicine, 43(2). https://doi.org/10.1111/dme.70179
Vancouver
Berthon W, McGurnaghan SJ, Blackbourn LAK, Fernandes AAS, Walker LE, McCrimmon RJ, et al. Polypharmacy and potentially inappropriate prescribing in people with type 2 diabetes: An analysis of the Scottish Diabetes Research Network national diabetes cohort. Diabetic Medicine. 2026;43(2). doi:10.1111/dme.70179
BibTeX
@article{Berthon2026,
author = {Berthon, William and McGurnaghan, Stuart J and Blackbourn, Luke A K and Fernandes, Amanda de Assuncao Santiago and Walker, Lauren E and McCrimmon, Rory J and Colhoun, Helen M and McAllister, David A and Hanlon, Peter},
title = {Polypharmacy and potentially inappropriate prescribing in people with type 2 diabetes: An analysis of the Scottish Diabetes Research Network national diabetes cohort},
journal = {Diabetic Medicine},
year = {2026},
volume = {43},
number = {2},
doi = {10.1111/dme.70179}
}
EUVIMED